Cargando…

SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus

Adults with Diabetes Mellitus (DM) have increased risk of severe clinical presentation during COVID-19 infection, while children and adolescents with type 1 diabetes (T1D) have the same mild clinical course as their healthy peers, especially those with optimal glycemic control. The present review fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karavanaki, Kyriaki, Karanasios, Spyridon, Soldatou, Alexandra, Tsolia, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543146/
https://www.ncbi.nlm.nih.gov/pubmed/37587391
http://dx.doi.org/10.1007/s12020-023-03471-y
_version_ 1785114236362424320
author Karavanaki, Kyriaki
Karanasios, Spyridon
Soldatou, Alexandra
Tsolia, Maria
author_facet Karavanaki, Kyriaki
Karanasios, Spyridon
Soldatou, Alexandra
Tsolia, Maria
author_sort Karavanaki, Kyriaki
collection PubMed
description Adults with Diabetes Mellitus (DM) have increased risk of severe clinical presentation during COVID-19 infection, while children and adolescents with type 1 diabetes (T1D) have the same mild clinical course as their healthy peers, especially those with optimal glycemic control. The present review focuses on the necessity of COVID-19 vaccination among children and adolescents with T1D, and also in their non-diabetic peers. The efficacy and safety of COVID-19 vaccines are also discussed, as well as their various side-effects, ranging from common mild to very rare and serious ones. Furthermore, the results of COVID-19 vaccination of adolescents with and without T1D are reported, as well as the efficacy and concerns about childhood vaccination. It is concluded that patients with DM of all age groups should maintain optimal diabetic control in order to avoid glycemic deterioration during COVID-19 infection. Furthermore, despite the very rare and serious complications of COVID-19 vaccines, vaccination against COVID-19 is recommended for children and adolescents with T1D to prevent glycemic deterioration and rare but serious complications of COVID-19 infection.
format Online
Article
Text
id pubmed-10543146
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-105431462023-10-03 SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus Karavanaki, Kyriaki Karanasios, Spyridon Soldatou, Alexandra Tsolia, Maria Endocrine Review Adults with Diabetes Mellitus (DM) have increased risk of severe clinical presentation during COVID-19 infection, while children and adolescents with type 1 diabetes (T1D) have the same mild clinical course as their healthy peers, especially those with optimal glycemic control. The present review focuses on the necessity of COVID-19 vaccination among children and adolescents with T1D, and also in their non-diabetic peers. The efficacy and safety of COVID-19 vaccines are also discussed, as well as their various side-effects, ranging from common mild to very rare and serious ones. Furthermore, the results of COVID-19 vaccination of adolescents with and without T1D are reported, as well as the efficacy and concerns about childhood vaccination. It is concluded that patients with DM of all age groups should maintain optimal diabetic control in order to avoid glycemic deterioration during COVID-19 infection. Furthermore, despite the very rare and serious complications of COVID-19 vaccines, vaccination against COVID-19 is recommended for children and adolescents with T1D to prevent glycemic deterioration and rare but serious complications of COVID-19 infection. Springer US 2023-08-16 2023 /pmc/articles/PMC10543146/ /pubmed/37587391 http://dx.doi.org/10.1007/s12020-023-03471-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Karavanaki, Kyriaki
Karanasios, Spyridon
Soldatou, Alexandra
Tsolia, Maria
SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
title SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
title_full SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
title_fullStr SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
title_full_unstemmed SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
title_short SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
title_sort sars-cov-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543146/
https://www.ncbi.nlm.nih.gov/pubmed/37587391
http://dx.doi.org/10.1007/s12020-023-03471-y
work_keys_str_mv AT karavanakikyriaki sarscov2vaccinationinchildrenandadolescentswithandwithouttype1diabetesmellitus
AT karanasiosspyridon sarscov2vaccinationinchildrenandadolescentswithandwithouttype1diabetesmellitus
AT soldatoualexandra sarscov2vaccinationinchildrenandadolescentswithandwithouttype1diabetesmellitus
AT tsoliamaria sarscov2vaccinationinchildrenandadolescentswithandwithouttype1diabetesmellitus